By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XBiotech USA, Inc. 

8201 E Riverside Drive
Building 4, Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-386-5107 Fax: n/a


Start Up

Company News
XBiotech (XBIT) Reports Affirmative Interim Analysis Of Global Phase III Colorectal Cancer Study 2/27/2017 8:44:49 AM
XBiotech (XBIT) Completes Dosing Of Subjects In PK Study Being Conducted In Connection With European Marketing Application 2/27/2017 8:43:10 AM
XBiotech (XBIT) Provides Update On Xilonix Phase III Programs In U.S. And EU 7/25/2016 8:32:37 AM
European Regulator Calls XBiotech (XBIT)'s Phase III Cancer Data Unreliable 7/15/2016 6:09:05 AM
2 Fallen Biotech Stocks Worth Chasing 7/7/2016 8:01:17 AM
XBiotech (XBIT)'s Colorectal Cancer Drug Claims Fall Apart, Shares Plummet 7/5/2016 7:54:20 AM
Xbiotech To Present Positive Preliminary Survival Data On Xilonix At The 18th European Society Of Medical Oncology’s World Congress On Gastrointestinal Cancer 5/24/2016 8:17:38 AM
XBiotech Provides First Quarter 2016 Corporate And Clinical Update 5/18/2016 10:20:33 AM
XBiotech Names Industry Veteran Dawn McCollough To Head Clinical Operations 5/16/2016 8:23:42 AM
XBiotech USA (XBIT) To Provide First Quarter 2016 Business Update On May 18 5/11/2016 10:11:32 AM